2nd Quarter - Report

DOW LOHNES GOVERNMENT STRATEGIES LLC for AMERISOURCEBERGEN CORPORATION

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Legislative proposals, including the President's proposed FY 2012 budget, to amend the Internal Revenue Code, provisions related to the last-in-first-out inventory accounting method.

LobbyistCovered position, as disclosed
M KENNETH BOWLER —
MICHAEL SCRIVNER Chief of Staff, Hon. Norman F. Lent, Jr.
AARON T WESTON New —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Medicare/Medicaid MMM

S. 733 and H.R. 905, provisions related to prompt pay discounts for drugs and biologicals under Medicare Part B.

LobbyistCovered position, as disclosed
M KENNETH BOWLER —
NORMAN LENT —
KENNETH D SALOMON —
MICHAEL SCRIVNER Chief of Staff, Hon. Norman F. Lent, Jr.

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 733 (112th), H.R. 905 (112th)

Pharmacy PHA

H.R. 1483, Drug Safety Enhancement Act of 2011, provisions related to pharmaceutical pedigree history, wholesale transaction documentation, and electronic tracking; Federal policy related to wet AMD pharmaceutical products and pricing.

LobbyistCovered position, as disclosed
M KENNETH BOWLER —
PETE LEON Legislative Director, Hon. Eliot Engel

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 1483 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.